Management of macular edema due to central retinal vein occlusion - The role of aflibercept.

about

Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

P2860

Q58567790-3F6BD88B-EBF0-4176-9C21-CEE4445346E5

P2860

Management of macular edema due to central retinal vein occlusion - The role of aflibercept.

Item

http://www.wikidata.org/entity/Q42359953

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Management of macular edema du ...... ion - The role of aflibercept.

@en

Management of macular edema du ...... ion - The role of aflibercept.

@nl

type

Item

label

Management of macular edema du ...... ion - The role of aflibercept.

@en

Management of macular edema du ...... ion - The role of aflibercept.

@nl

prefLabel

Management of macular edema du ...... ion - The role of aflibercept.

@en

Management of macular edema du ...... ion - The role of aflibercept.

@nl

P1476

Management of macular edema du ...... ion - The role of aflibercept.

@en

P2093

Diana V Do

http://www.w3.org/2001/XMLSchema#string

Drew Dickson

http://www.w3.org/2001/XMLSchema#string

Quan Dong Nguyen

http://www.w3.org/2001/XMLSchema#string

William Rhoades

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia

Cytokine traps: multi-component, high-affinity blockers of cytokine action

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data

The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.

The burden of disease of retinal vein occlusion: review of the literature.

The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

P304

70-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/TJO.TJO_9_17

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29018760

http://www.w3.org/2001/XMLSchema#string

P932

5602151

http://www.w3.org/2001/XMLSchema#string

Management of macular edema due to central retinal vein occlusion - The role of aflibercept.

about

P2860

P2860

Management of macular edema due to central retinal vein occlusion - The role of aflibercept.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932